Pharmaceuticals, Biotechnology and Life Sciences
COPENHAGEN, Denmark, Aug. 17, 2021 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative…
KEEGO HARBOR, Mich., Aug. 17, 2021 (GLOBE NEWSWIRE) — Zivo Bioscience, Inc. (NASDAQ: ZIVO, ZIVOW) (“ZIVO” and the “Company”), a…
— PDUFA Date Set for February 17, 2022 –CAMBRIDGE, Mass., Aug. 17, 2021 (GLOBE NEWSWIRE) — Agios Pharmaceuticals, Inc. (NASDAQ:…
CAMBRIDGE, Mass., Aug. 17, 2021 (GLOBE NEWSWIRE) — Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company engineering a novel…
MELBOURNE, Australia and ADELAIDE, Australia, Aug. 17, 2021 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) today…
MELBOURNE, Australia and LONDON , Aug. 17, 2021 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today…
Continued strength in unit demand across key product lines Rupall unit demand growth of 44% for the 12 months ending…
PORTLAND, Ore., Aug. 16, 2021 (GLOBE NEWSWIRE) — Chalice Brands Ltd., formerly Golden Leaf Holdings Ltd. (CSE: CHAL) (OTCQB: CHALF)…
Secured funding of approximately $138 million through merger and private placement investment in public equity (PIPE) financingExpanded Phase 1 clinical…
EMERYVILLE, Calif., Aug. 16, 2021 (GLOBE NEWSWIRE) — Zogenix (NASDAQ: ZGNX) today announced that the compensation committee of the company’s board…